Literature DB >> 31572810

Virulence Factors and Antibiotic Resistance of Avian Pathogenic Escherichia Coli in Eastern China.

Xiaojing Xu1, Qing Sun2,3, Lixiang Zhao1.   

Abstract

INTRODUCTION: Avian pathogenicEscherichia coli (APEC) causes serious colibacillosis and significant economic losses. Data on profiles of virulence factors and antibiotic resistances among APEC strains are crucial to the control of infection. In this study, strains were isolated from eastern China, and the prevalence of virulence factors and distribution of antibiotic resistance were determined.
MATERIAL AND METHODS: APEC strains were isolated and characterised by PCR for O serogroups, virulence factor genes, antibiotic resistance, and phylogenetic groups.
RESULTS: O78 was the most prevalent serogroup and type A was the most frequent phylogenetic group. ThefimH,feoB, andiron genes were the most prevalent among the isolates. All isolates were multiresistant, and all strains were resistant to ampicillin and tetracycline, which are widely used in the poultry industry in China.
CONCLUSION: This study provided important data on the presence of virulence genes and antibiotic resistance profiles of APEC from poultry farms in eastern China.
© 2019 X. Xu et al. published by Sciendo.

Entities:  

Keywords:  Escherichia coli; antibiotic resistance; chicken; phylogenetic group; virulence factors

Year:  2019        PMID: 31572810      PMCID: PMC6749729          DOI: 10.2478/jvetres-2019-0056

Source DB:  PubMed          Journal:  J Vet Res        ISSN: 2450-7393            Impact factor:   1.744


Introduction

Escherichia coli is considered a normal part of the intestinal microflora in humans and birds. Certain avian pathogenicE. coli strains (APEC) are accepted to be the main causes of avian colibacillosis, which manifests as pericarditis, perihepatitis, peritonitis, airsacculitis, and septicaemia, and causes significant economic losses worldwide every year (1, 8). The pathogenic ability of APEC is mediated by a broad range of virulence factors, such as colonisation factors (facilitating attachment of APEC to extraintestinal tracts), adhesins (also facilitating attachment of APEC to extraintestinal tracts and assisting penetration of bacteria into the tissues), toxins (protecting APEC from lysosomes), siderophores (chelating iron), and protectins (inhibiting the classical pathway of complement activity), which help the bacterial infection to become established and augment the bacterium’s resistance to the host’s immune defences. Epidemic data show that human extraintestinal pathogenicE. coli (ExPEC) strains and APEC often carry similar virulence genes, suggesting the zoonotic importance of APEC strains. Antibacterial drugs have been widely used in the poultry industry to control APEC infection (4). In many countries, including China, antibacterial drugs have been used as therapeutic methods and for prevention of infection and growth promotion (5). However, excessive use of antimicrobials in food-producing animals has led to several adverse effects on animals, humans, and the environment. Meanwhile continuous administration of antibacterial drugs leads to the emergence of multi– drug-resistant strains (MDR) ofE. coli (6). These strains can be transmitted to people through the food chain resulting in a serious risk to human health. Drug resistance has consequently become a focus of interest for both the poultry industry and public healthcare in China. Data on profiles of virulence factors and antibiotic resistances among APEC strains are crucial to infection control in China. In this study, we isolated strains from eastern China and determined the prevalence of virulence factors, distribution of antibiotic resistance, and phylogenetic background of these isolates.

Material and Methods

Bacterial strains. Samples of the liver, lungs, air sacs, and spleen from infected chickens with typical lesions ofE. coli infections were collected from farms in the Jiangsu and Shandong provinces from 2005 to 2008. Samples were cultured on MacConkey agar overnight at 37°C, and suspect bacterial colonies were further isolated on LB agar. The isolates were kept at −70°C with the addition of 20% (v/v) glycerol. For each sample, only one colony was isolated and used for subsequent examination. The serotyping of each strain was carried out according to the standard methods of the Chinese Institute of Veterinary Drug Control. Briefly, 21 sets of polyvalent antisera against 174 O serogroups (Tianjin Biochip Corporation, Tianjin, China) were used to determine the O serogroups of each strain using agglutination tests according to the manufacturer’s instructions. Phylogenetic type and gene virulence detection. Bacterial DNA were extracted using Rapid DNA extraction kits according to the manufacturer’s protocol (Tiangen Biotech, Beijing, China). The phylogenetic types were determined by a PCR targeting three genes ChuA,YjaA, and TSPE4.C2) as previously described (11). Virulence genes totalling 33 were determined by a PCR targetingiucC and six sets of multiplex PCRs targeting different sets of the following genes: 1)papA,fimH,kpsMT III,papEF,ireA, andibeA; 2)cnf-1,fyuA,iroN,bmaE,sfa,iutA, andpapG allele III; 3)hlyD,rfc,ompT,papG allele I ,kpsMT II, andpapC; 4)gafD,cdtB,traT, andpapG allele II; 5)papG allele I,iha,afa,iss,sfaS, andkpsMT (K1); and 6)sitA,feoB, andirp-2 (11). Antimicrobial resistance testing. A total of nine antimicrobial drugs (ampicillin (AMP 10 μg), cefotaxime (CTX 30 μg), chloramphenicol (30 μg), gentamicin (10 μg), kanamycin (30 μg), nalidixic acid (30 μg), streptomycin (10 μg), sulphamethoxazoletrimethoprim (STX 1.25/23.75 μg), and tetracycline (TET 30 μg)) were used for antimicrobial susceptibility testing by the Kirby–Bauer method according to the National Committee for Clinical Laboratory Standards interpretive criteria.

Results

Serotyping of the isolates. In total 106 APEC strains were isolated and 77 (72.64%) strains were O-antigen typable. Most of the O-antigen typable strains belonged to O78 (19 isolates), O2 (6 isolates), O18 (6 isolates), O45 (5 isolates), O1 (5 isolates), and O4 (3 isolates). Phylogenetic typing. Phylogenetic types were determined using PCR, and phylotype A proved to be the most prevalent phylogenetic group, to which 44.34% (47 out of 106) affiliated. In the remaining 59 isolates, 32 belonged to phylogenetic group B2, 15 to B1, and 12 to D (Table 1). The correlation of the O-serotype with the phylogenetic group was also examined (Table 2).
Table 1

Phylogenetic groups of 106 APEC strains

Phylogenetic groupNumberPercentage
A4743.34
B11514.15
B23230.19
D1211.32
Table 2

Correlation of the O-serotype with the phylogenetic group

Phylogenetic group
O-serotypeAB1B2DTotal
O122105
O232016
O420103
O1842006
O4521115
O78853319
Phylogenetic groups of 106 APEC strains Correlation of the O-serotype with the phylogenetic group Genotyping of virulence genes. The prevalence of 33 virulence genes in each APEC strain was screened by PCR (Table 3). The results showed thatfimH,feoB, andiron were the most prevalent genes among all isolates, exceeding 90% in each case. More than 70% of isolates also carried theireA,irp-2,iutA,ompT,iss, ortraT genes. Four virulence genes iha,rfc,cnf-1, andhlyD) were not detected in this study.
Table 3

Prevalences of virulence factors in 106 APEC strains

Virulence factor genesNumberPercentage
Adhesins
Afa21.89
bmaE10.94
fimH10296.22
focG21.89
Iha00
papA4239.62
papC4744.34
papEF4340.57
papG allele I1312.26
papG allele II65.66
papG allele III76.60
Sfa10.94
SfaS10.94
Iron chelation genes
feoB10195.28
fyuA5955.66
ireA7671.70
iroN9892.45
irp-28176.42
iucC7267.92
iutA8782.08
sitA6258.49
Miscellaneous
ibeA3028.30
malX3331.13
Protectins
Iss8782.08
kpsMT (K1)6359.43
kpsMT II5854.72
kpsMT III1211.32
Rfc00
traT8782.08
ompT8983.96
Toxins
cdtB21.89
cnf-100
hlyD00
Prevalences of virulence factors in 106 APEC strains Antimicrobial resistance. Antimicrobial resistance test results showed that the isolates were commonly resistant to the tested antibiotics (Table 4). All isolates exhibited resistance to ampicillin and tetracycline. The frequencies of resistance to other antimicrobials were 89.62% to nalidixic acid, 83.96% to chloramphenicol, 80.19% to kanamycin, 64.15% to streptomycin, 58.49% to sulphamethoxazole-trimethoprim, 53.77% to cefotaxime, and 50.00% to gentamicin. All of the isolates were multi-drug–resistant (MDR) strains.
Table 4

Antibiotic resistance of 106 APEC strains

AntibioticsNumber of resistant strainsPercentage of resistant strains
Ampicillin106100
Cefotaxime5753.77
Chloramphenicol8983.96
Gentamicin5350.00
Kanamycin8580.19
Streptomycin6864.15
Sulphamethoxazole-trimethoprim6258.49
Nalidixic acid9589.62
Tetracycline106100
Antibiotic resistance of 106 APEC strains

Discussion

The poultry industry is developing rapidly in many regions of China. Colibacillosis is one of the major diseases blighting the poultry industry and antibiotics are widely used in its control. However, the emergence of multi-drug–resistant APEC strains has often led to the failure of antibiotics to control APEC infections. In many regions of China, data on virulence genes and antibiotic resistance of APEC are often unavailable. In the present study, APEC strains were isolated from chickens affected with colibacillosis, and virulence factor genes and antibiotic resistance were determined. APEC isolates often carried a broad range of virulence genes. O-antigens, one of the well-documented virulence factors ofE. coli, can protect bacteria from clearance by the neutrophils and macrophages of the host (2). A specific O-antigen (such as O1, O2, and O78) is often associated with the virulence of APEC strains (3), and APEC isolates with O-antigens are considered virulent. Here, we found that O78 and O2 are the dominant strains among APEC isolates from eastern China, which is consistent with other research from Egypt (10), suggesting wide distribution of these two O-antigens in virulent APEC. Adhesin is the most important gene which helps the bacteria colonise host cells to build infection. Most APEC isolates from the current study carried one of the most important adhesin-encoding genes,fimH. Thepap gene cluster, encoding a pilus rod, was also present in high prevalence. Thesfa gene, encoding S fimbriae, occurred in very low prevalence. S fimbriae, one of the mannose-resistant adhesins, often occurred in other ExPEC strains, namely strains of uropathogenicE. coli, and the very low prevalence ofsfa in APEC suggested the important role of this adhesin in urinary infections rather than in avian infection by ExPEC (7). The polysialic acid capsule–encoding gene kpsMT) is one of the important virulence factors which shieldE. coli from lysis by lysosomes, and over 50% of APEC isolates carry this gene.OmpT promotes formation of bacterial communities during APEC infection, and more than 80% of APEC isolates possess it, suggesting the essential role of this gene in APEC infection. Excessive use of antimicrobials in chicken has led to several adverse effects on animals, humans, and the environment. Our data demonstrated that the antibiotic resistance of APEC isolated from eastern China is a serious concern. Out of nine antibiotics tested, none showed more than 50% effectiveness against the APEC strains, and as the least resisted antibiotic, gentamicin was inefficacious with 50% of APEC strains. All APEC strains were resistant to ampicillin and tetracycline. It could result from the wide use of these antibiotics in the poultry industry in eastern China. About 90% of strains in this study were resistant to nalidixic acid, which was a higher percentage than strains isolated from Belgium and North Georgia (9, 12). The reason may be the relatively high utilisation of nalidixic acid in eastern China. In summary, the APEC isolates in the present study carried a set of virulence factors, and these isolates also exhibited high rates of resistance to commonly used antibiotics, which could cause a serious public health problem.
  12 in total

1.  In vivo efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses.

Authors:  Ana Oliveira; Rui Sereno; Joana Azeredo
Journal:  Vet Microbiol       Date:  2010-05-13       Impact factor: 3.293

2.  An experimental infection model for Escherichia coli egg peritonitis in layer chickens.

Authors:  Atul A Chaudhari; Subhashinie Kariyawasam
Journal:  Avian Dis       Date:  2014-03       Impact factor: 1.577

3.  Uropathogenic Escherichia coli isolates with different virulence genes content exhibit similar pathologic influence on Vero cells.

Authors:  Jamil M A S Obaid; Samira R Mansour; Mohammed S Elshahedy; Tarik E Rabie; Adel M H Azab
Journal:  Pol J Microbiol       Date:  2014

4.  Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates.

Authors:  Shaohua Zhao; John J Maurer; Susannah Hubert; Juan F De Villena; Patrick F McDermott; Jianghong Meng; Sherry Ayers; Linda English; David G White
Journal:  Vet Microbiol       Date:  2005-02-23       Impact factor: 3.293

5.  Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry.

Authors:  Christa Ewers; Traute Janssen; Sabine Kiessling; Hans-C Philipp; Lothar H Wieler
Journal:  Vet Microbiol       Date:  2004-11-30       Impact factor: 3.293

6.  Detection of phenotypes, virulence genes and phylotypes of avian pathogenic and human diarrheagenic Escherichia coli in Egypt.

Authors:  Hazem Ramadan; Amal Awad; Ahmed Ateya
Journal:  J Infect Dev Ctries       Date:  2016-06-30       Impact factor: 0.968

7.  Susceptibility of avian pathogenic Escherichia coli from laying hens in Belgium to antibiotics and disinfectants and integron prevalence.

Authors:  Leon H Oosterik; Laura Peeters; Irene Mutuku; Bruno M Goddeeris; Patrick Butaye
Journal:  Avian Dis       Date:  2014-06       Impact factor: 1.577

8.  Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E. coli in a murine urinary tract infection model and a chicken challenge model.

Authors:  Lixiang Zhao; Song Gao; Haixia Huan; Xiaojing Xu; Xiaoping Zhu; Weixia Yang; Qingqing Gao; Xiufan Liu
Journal:  Microbiology       Date:  2009-04-16       Impact factor: 2.777

Review 9.  Advances in vaccination against avian pathogenic Escherichia coli respiratory disease: potentials and limitations.

Authors:  Haitham Ghunaim; Marwan Abdelhamid Abu-Madi; Subhashinie Kariyawasam
Journal:  Vet Microbiol       Date:  2014-05-05       Impact factor: 3.293

10.  Antimicrobial use in Chinese swine and broiler poultry production.

Authors:  Vikram Krishnasamy; Joachim Otte; Ellen Silbergeld
Journal:  Antimicrob Resist Infect Control       Date:  2015-04-28       Impact factor: 4.887

View more
  10 in total

1.  Phylogenetic relationship and virulence gene profiles of avian pathogenic and uropathogenic Escherichia coli isolated from avian colibacillosis and human urinary tract infections (UTIs).

Authors:  A R Ghorbani; R Khoshbakht; H Kaboosi; H Shirzad-Aski; F Peyravii Ghadikolaii
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

2.  Comparative Characteristics and Zoonotic Potential of Avian Pathogenic Escherichia coli (APEC) Isolates from Chicken and Duck in South Korea.

Authors:  Jiyeon Jeong; Ji-Youn Lee; Min-Su Kang; Hye-Jin Lee; Seong-Il Kang; O-Mi Lee; Yong-Kuk Kwon; Jin-Hyun Kim
Journal:  Microorganisms       Date:  2021-04-27

3.  Investigation of Serotype Prevalence of Escherichia coli Strains Isolated from Layer Poultry in Greece and Interactions with Other Infectious Agents.

Authors:  Dimitrios Koutsianos; Labrini V Athanasiou; Dimitris Mossialos; Giovanni Franzo; Mattia Cecchinato; Konstantinos C Koutoulis
Journal:  Vet Sci       Date:  2022-03-23

4.  Genome evolution and the emergence of pathogenicity in avian Escherichia coli.

Authors:  Leonardos Mageiros; Guillaume Méric; Sion C Bayliss; Johan Pensar; Ben Pascoe; Evangelos Mourkas; Jessica K Calland; Koji Yahara; Susan Murray; Thomas S Wilkinson; Lisa K Williams; Matthew D Hitchings; Jonathan Porter; Kirsty Kemmett; Edward J Feil; Keith A Jolley; Nicola J Williams; Jukka Corander; Samuel K Sheppard
Journal:  Nat Commun       Date:  2021-02-03       Impact factor: 14.919

Review 5.  Avian Pathogenic Escherichia coli (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies.

Authors:  Dipak Kathayat; Dhanashree Lokesh; Sochina Ranjit; Gireesh Rajashekara
Journal:  Pathogens       Date:  2021-04-12

6.  Effects of in ovo probiotic administration on the incidence of avian pathogenic Escherichia coli in broilers and an evaluation on its virulence and antimicrobial resistance properties.

Authors:  Tianmin Li; Claudia D Castañeda; Julio Miotto; Chris McDaniel; Aaron S Kiess; Li Zhang
Journal:  Poult Sci       Date:  2020-12-10       Impact factor: 3.352

7.  Virulence Profiles and Antibiotic Susceptibility of Escherichia coli Strains from Pet Reptiles.

Authors:  Marta Dec; Dagmara Stepien-Pysniak; Klaudiusz Szczepaniak; Barbara Turchi; Renata Urban-Chmiel
Journal:  Pathogens       Date:  2022-01-21

8.  Comparative Characteristics and Pathogenic Potential of Escherichia coli Isolates Originating from Poultry Farms, Retail Meat, and Human Urinary Tract Infection.

Authors:  Jolanta Sarowska; Tomasz Olszak; Agnieszka Jama-Kmiecik; Magdalena Frej-Madrzak; Bozena Futoma-Koloch; Andrzej Gawel; Zuzanna Drulis-Kawa; Irena Choroszy-Krol
Journal:  Life (Basel)       Date:  2022-06-06

9.  Isolation, Molecular Characterization, and Antibiotic Resistance of Avian Pathogenic Escherichia coli in Eastern China.

Authors:  Dossêh Jean Apôtre Afayibo; Hong Zhu; Beibei Zhang; Lan Yao; Hosny Ahmed Abdelgawad; Mingxing Tian; Jingjing Qi; Yali Liu; Shaohui Wang
Journal:  Vet Sci       Date:  2022-06-25

10.  Virulence Factors and Antimicrobial Resistance Profile of Escherichia Coli Isolated from Laying Hens in Italy.

Authors:  Lorenzo Gambi; Rachele Rossini; Maria Luisa Menandro; Giovanni Franzo; Francesco Valentini; Giovanni Tosi; Mario D'Incau; Laura Fiorentini
Journal:  Animals (Basel)       Date:  2022-07-15       Impact factor: 3.231

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.